In T2DM mice, Kv1.3 blockade reduces weight gain and associated inflammation, improves glucose tolerance, and eliminates insulin resistance (Upadhyay et al., 2013; Arevalo-Martinez et al., 2021). The gene discussed is KCNA3; the disease is type 2 diabetes mellitus.